Michael Newman
Seminars
Wednesday 19th November 2025
Creating Super Donor Cells Post-Donation – Using Attenuated and Killed Bacteria to Induce, Polarize, and Activate Human Innate and Adaptive Immune Cells In Vitro
12:00 pm
- Reviewing Indaptus’ clinical stage attenuated and killed, multi-immune agonist Decoy bacterial platform in development for advanced solid tumors
- Demonstrating induction, polarization, and/or activation of M1 macrophages, NK cells, gamma-delta T cells, and T lymphocytes by Decoy bacteria in vitro
- Suggesting that GMP Decoy bacteria may represent an ideal treatment to enhance activity and reduce variability during manufacturing of allogeneic cell therapies
